Richard Aplenc Selected Research

Richard Aplenc Research Topics

Disease

68	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2004
35	Neoplasms (Cancer) 04/2024 - 07/2003
35	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 08/2002
27	Leukemia 01/2024 - 06/2005
7	Cytokine Release Syndrome 01/2022 - 04/2013
7	Neutropenia 01/2022 - 05/2013
6	Sepsis (Septicemia) 01/2023 - 08/2005
6	Breast Neoplasms (Breast Cancer) 06/2020 - 08/2005
5	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 05/2014
5	Cardiotoxicity 01/2023 - 10/2009
5	Infections 11/2016 - 04/2007
4	Residual Neoplasm 02/2024 - 01/2020
4	Left Ventricular Dysfunction 01/2023 - 12/2010
4	Fever (Fevers) 01/2022 - 11/2009
4	Neuroblastoma 01/2021 - 06/2014
4	Acute Lung Injury 05/2011 - 07/2007
3	Down Syndrome (Down's Syndrome) 01/2023 - 11/2016
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 04/2007
3	Myeloid Leukemia (Leukemia, Myelocytic) 07/2017 - 03/2013
3	Wounds and Injuries (Trauma) 05/2011 - 10/2008
2	Septic Shock (Toxic Shock Syndrome) 11/2023 - 06/2013
2	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 01/2022
2	Multiple Myeloma 01/2023 - 01/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2018
2	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 01/2022
2	Hyperbilirubinemia 01/2022 - 08/2005
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 11/2014
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 06/2013
2	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 06/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021 - 04/2013
2	Critical Illness (Critically Ill) 10/2020 - 01/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 07/2003
2	Primary Graft Dysfunction 02/2015 - 03/2014
2	Clostridium Infections 12/2014 - 05/2013
2	Body Weight (Weight, Body) 10/2014 - 04/2013
1	Trisomy (Trisomies) 01/2023
1	Tics (Tic) 01/2023
1	Monosomy 01/2023

Drug/Important Bio-Agent (IBA)

13	Gemtuzumab (Mylotarg)FDA Link 01/2024 - 08/2005
11	Chimeric Antigen ReceptorsIBA 04/2024 - 04/2013
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2009
7	tisagenlecleucelIBA 02/2024 - 04/2013
6	AnthracyclinesIBA 01/2023 - 08/2005
6	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2023 - 04/2013
5	Bortezomib (Velcade)FDA Link 04/2024 - 01/2017
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2020
5	CytokinesIBA 10/2020 - 04/2007
4	EnzymesIBA 05/2012 - 08/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2024 - 01/2021
3	AntigensIBA 04/2024 - 05/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	nuclear pore complex protein 98IBA 01/2023 - 12/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
3	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021 - 01/2014
3	tocilizumab (atlizumab)FDA Link 10/2021 - 04/2013
3	Oxidants (Oxidizing Agents)IBA 02/2015 - 07/2007
3	Cytochrome P-450 CYP3AIBA 08/2005 - 07/2003
2	Proteasome InhibitorsIBA 04/2024 - 01/2014
2	CalicheamicinsIBA 01/2024 - 04/2016
2	insulin receptor-related receptor (IRR)IBA 01/2023 - 05/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2022
2	Transaminases (Aminotransferases)IBA 01/2022 - 08/2005
2	ProteomeIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 05/2016
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 01/2004
2	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 05/2013
2	Monoclonal AntibodiesIBA 01/2018 - 01/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 08/2002
2	Immunoconjugates (Immunoconjugate)IBA 08/2017 - 09/2014
2	Prostaglandins DIBA 02/2015 - 03/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2014 - 12/2009
2	Dasatinib (BMS 354825)FDA Link 03/2011 - 12/2009
2	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 12/2009
2	Estrogen ReceptorsIBA 01/2010 - 05/2009
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2010 - 10/2004
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2005 - 03/2005
1	ChromatinIBA 04/2024
1	Uric Acid (Urate)IBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 03/2023
1	Long Noncoding RNAIBA 01/2023
1	A 17 (A-17)IBA 01/2022

Therapy/Procedure

47	Therapeutics 04/2024 - 08/2002
44	Drug Therapy (Chemotherapy) 04/2024 - 08/2005
4	Induction Chemotherapy 12/2021 - 03/2013
4	Cell Transplantation 01/2021 - 11/2017
4	Transplantation 01/2021 - 09/2008
4	Immunotherapy 01/2021 - 01/2014
4	Critical Care (Surgical Intensive Care) 01/2018 - 02/2014
3	Length of Stay 01/2019 - 10/2014
3	Adjuvant Chemotherapy 01/2010 - 08/2005
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2021
2	Stem Cell Transplantation 01/2022 - 01/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2014 - 09/2008
1	Secondary Prevention 02/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Catheters 01/2023